Complex Mechanisms of Disease, Aging and Trauma (CMDAT) Research Foundation, Denver, CO, USA.
Institute for Experimental and Clinical Research (IREC), Université Catholique Louvain (UCL, Brussels, Belgium.
Hosp Pract (1995). 2022 Feb;50(1):37-41. doi: 10.1080/21548331.2021.2016334. Epub 2021 Dec 20.
Our project aimed to increase knowledge of noninvasive diagnostic modalities (including bone radiotracer scintigraphy), raise suspicion of transthyretin cardiac amyloidosis (ATTR-CA), and improve cardiology team member's awareness and knowledge of shared decision-making (SDM), as well as the quality of SDM communication between cardiology team members and patients.
An online educational module and survey was developed and cardiology team members in Colorado, USA, were invited to participate. This online educational module included various important topics related to ATTR-CA (e.g., the cause of ATTR-CA, endomyocardial biopsy, and noninvasive methods to diagnose ATTR-CA) and SDM (e.g., benefits of SDM, the role of SDM in the diagnosis of ATTR-CA, implementation of SDM in cardiology practice, and the 3-talk model).
There were 34 survey respondents, over one-third of whom were cardiologists. Most respondents agreed on the importance of diagnosing ATTR-CA at an early stage, and about three-quarters of the survey takers agreed that bone scintigraphy can reliably diagnose ATTR-CA without the need for endomyocardial biopsy. Concern over increased time commitment was the leading barrier to the implementation of SDM in respondents' clinical practice. The majority of respondents identified the correct answer regarding ATTR-CA and SDM after reading the online educational module. This improvement in scores after exposure to the online educational module was statistically significant.
Baseline knowledge and awareness of various issues related to ATTR-CA was relatively low among cardiology team members. Participants' knowledge was enhanced through our effective online educational program. Prospective educational projects focused on various methods of detecting ATTR-CA as well as other amyloid conditions in diverse clinical settings will remain important.
我们的项目旨在提高对无创诊断方法(包括骨骼放射性示踪剂闪烁照相术)的认识,提高对转甲状腺素蛋白心脏淀粉样变性(ATTR-CA)的警惕,并提高心脏病学团队成员对共享决策(SDM)的认识和了解,以及心脏病学团队成员与患者之间 SDM 沟通的质量。
开发了一个在线教育模块和调查,并邀请美国科罗拉多州的心脏病学团队成员参与。这个在线教育模块包括与ATTR-CA(例如ATTR-CA 的原因、心内膜心肌活检和诊断ATTR-CA 的非侵入性方法)和 SDM(例如SDM 的益处、SDM 在诊断ATTR-CA 中的作用、SDM 在心脏病学实践中的实施以及 3 谈模型)相关的各种重要主题。
有 34 名调查受访者,其中超过三分之一是心脏病专家。大多数受访者认为早期诊断ATTR-CA 非常重要,大约四分之三的调查参与者同意骨骼闪烁照相术可以可靠地诊断ATTR-CA,而无需进行心内膜心肌活检。增加时间承诺的担忧是阻碍 SDM 在受访者临床实践中实施的主要障碍。大多数受访者在阅读在线教育模块后,对与ATTR-CA 和 SDM 相关的问题的正确答案有了清晰的认识。在接触在线教育模块后,分数的提高具有统计学意义。
心脏病学团队成员对与ATTR-CA 相关的各种问题的基本知识和认识相对较低。我们的有效在线教育计划提高了参与者的知识水平。针对在各种临床环境中检测ATTR-CA 以及其他淀粉样变性疾病的各种方法的前瞻性教育项目仍将很重要。